Brief: UTHealth In Houston And Athersys Announce Commencement Of Patient Enrollment In A Phase 2 Trial Evaluating Multistem Cell Therapy In Trauma
21/12/2020 11:21
Dec 21 (Reuters) - Athersys Inc ATHX.O :
* UTHEALTH IN HOUSTON AND ATHERSYS ANNOUNCE COMMENCEMENT OF
PATIENT ENROLLMENT IN A PHASE 2 TRIAL EVALUATING MULTISTEM® CELL
THERAPY IN TRAUMA
Source text for Eikon: ID:nBw9T3MYKa
Further company coverage: ATHX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Athersys
See all newsBrief: Athersys Anticipates Terminating Remaining Employees, Effective December 31
Brief: Athersys Extends Near Term Liquidity With Proceeds From Warrant Inducement
U.S. STOCKS ON THE MOVE-Hyatt Hotels, Walmart, Maxeon
U.S. STOCKS ON THE MOVE-Olema Pharma, Akamai Technologies, US banks
Athersys hits record low on flagging bankruptcy risk